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R<,~lrr~,r~r. Mi,#,WW,,,, 
Balloon aorlic valvulopla~ly ha\ been wed for pallis~~on of 
aortic stenosis in ,elecled penems aho for LXIOUI ream\ 
has been used in younger pal& uho haw co&em 
severe noncardiac disease. Other inve\ugatot\ t 111 hate 
reported that the resuI& of hallooa im”,c vrlvnlopla\!) n.,! 
be baser in younger than m older pal~cnlt Indeed. thn 
ccmcepl ha5 encouraged some remen IO ,dvoc.oe perfor- 
mance of balloon aontc valvulopla\tv a\ :t pnmilrv pmce- 
durc in younger pahem\ (14) .Althooph manv fwort un- 
doubtedly determine immedlatr dnd lonp-term ounxnc~ of 
balloon sonic valvulopla~~y. one hypothew I\ that yoonpr 
patients may have le\r advanced annic valve d~w;w. allow 
ing larger increaw m valve openmg md finnl iaontc t.d\c 
area. 
Methods 
The Repklr!. The Man\Rcld Scientific Aontc Valvulo- 
pl.~rn Kegq) compnrer data pro~pecuvely collected from 
27 psnlclp;ltlnl!cenler, involved in the performanccofaonic 
h.dkmn \alvulopla,,y. Ddla formr from each center were 
prorlded for each patient undergoing balloon sonic valvulo- 
,,!a\~> a, lhal center and rhc\c were ,eilt to Man,fwld 
Fucnl~fic Ior collal~on and *lalntical analywr. At initial 
evalua~mn. ha\elinc clinical and laboratory data were re- 
corded on each individual. including meawrements made at 
cardw cxtheterintion and before and after balloon aorlic 
vnlvulopla\ty Follow-up wt performed by clinician wit\ 
and telephone mtervicw at 3 month mwval~. 
Data analy5ir. In order 10 compare rewll$ III patients of 
d~flerwn .~pel\l. the patienti\l were divided into three 
group\’ 1ho.e < 70 year, ofage. tho\e 70 to 79 years of ape. 
anil Iho\e -.X0 year, of age. Successful valvulopla~ty w’as 
d&cd a\ an mcreare m valve area of 35%. or a decrease 
in prcwrc gradient of ~50%. or both. in surviving patients 
~ooi reqomnp sonic valve replacement during ho$pilaliza- 
uon End points for immediate rewlt~ included aortic valve 
.trea and peak +iolic gradient. procedural complicalimn 
and morulity. Follow-up end points included need for sonic 
\alve replacement or repeal valvuloplariy. monslity a.J 
funchonal clas. All patient5 had 81 least one 6 month 
Baseline clinical characlrrirtics (Tables I lo 3). Baseline 
chanctcn\tic\ for the 492 palicnlr undergoing balloon aorlic 
valvulopla\ty in Ihe Mlan\field Registry are shown in Table I. 
Fdly-nmc palienlr were ~711 years oi age ar the lime of 
valvulopla\ty. IbR were 70 10 79 years of age and 265 were 
GO yra:\ of age. The proportion of female LO male palienls 
mcrea\cd m the older se group5 Ip ‘. 0.0%). Of patents 
‘-80 yean of sge. 63% were female. almost twice as great ar 
the percent of female patient* <70 years of age. 
For ench tgc group. valve area decreased with mcrearins 
ace (p < 0.001). Bccau>~‘of the mcrea\!“% prop”rUo” I” Ihc 
larger groups of women with prerunubl) vmallcr hod! 
surface area. valve area was nom,ab~cd for budy \urf~c 
area. creating a valve area Index. AI crpcctcd. the vales 
area index also decreased with increarinp xge. from 0.34 z 
0.09 cm%+ in palient5 <70 Lean. 0 31 f 0 I I cm% m 
those 70 10 79 years and 0.29 r 0 I I cm% nn iho,c 280 
,ean of age Ip < 0.011. Peak qs~obc i&c gradw!i mca- 
sured al catheterization ranged from I5 10 M) mm Hg and ~a* 
not cubstantially dafferent among the lhrre group*. Horh 
cardiac output and cardiac index dccreaed vgsnicall> v. Ich 
increasing patient age. The presence and wveri:) oi .,on~ 
regurgitation did not differ suhstanxdly among the three rce 
grO”p5. 
Coronu~ orlerioprup$. uas performed m a urnllar ma- 
jority of palvats in all three group\ (Table 2). There wre no 
sipnificanl ditierences in number> of paiient, ullh ringlc. 
double and triple revel coronar) dxnvz. 
rtaustically dikmnt among the proupr. 
Outcome at last tollou-up (Table 51. The mean dwation of 
follow-up WE :;pproxlmalely 1 monthx all patient5 were 
followed up for at lea\! 6 months. The number of patient\ 
who showed improvement al follow-up decreased ulth age. 
ranging from 67% in patients <70 lo 60% in palientr rRO 
years of a&xc (p = NSI. Similarly. there war lea\ improve- 
ment in functional clar> in the older patients. Hwevcr. 
significantly more p;ltienl\ were in funclionnl cla\s ii1 or IV 
in the @oup SXO yearr ofage than in Ihe wn )oungcrgroup~ 
Ip = O.lX)I L The 6 month mortality rale ww highest in 
palientr >80 I?E%I. next highest in patients <70 (24%) and 
lowest m palien 70 10 79 year, of age (IS%. p = 0.01 Il. 
Other evenls record-d al h month5 taor;ic valve replacemen! 
or repeat valvuloplastyl acre least common in patients 280 
and mosl comnwn in p&ems ~70 years of ag (p = O.W7i. 
Uniwriurr wni~* b of 20 sdrt?rd wuiuhlus demonrtraled 
that only ejwtion frdclion and cardiac oulput before YBIYUIO- 
plasty were ,Ggnificandy related to monalily at follow-up in alI 
three age soups. Multivariate an&+ produced dissimilar 
discriminaa fur&u fur each age group. However. in gcn- 
eral. meamrc~ of left ~entticular function and cardiac output 
again were important factors in the multixmate xxalyri\. 
Discussion 
Aortic valvuloplarry ha\ been thought to yield helter 
results in younger patients. probably because there is less 
severe Ihackening. calcification and rigidity of sonic cmps. 
Younger patients alro may have a higher prevalence of 
bicuspid amic slenosis and rheumatic aonic valve disease in 
ccmtra~t 10 the senile calcdic rrenosis seen in older padents. 
The prevalence of each of these anatomic subtypes rem&d?% 
undetermmcd in tb, and all other clinical studies of balloon 
ralvulopla~ly. 
lnmadiale results. In this reg~try study. older patienls 
did have more severe sonic stenosis at baseline awssme~t 
of salve arm ewn after correction for differences in body 
surface area. However. the incidence of successful valvulo- 
pla%ty. a5 assewed by increase, in valve area and indexed 
valve area and a decrease in pressure gradient. was cornpa- 
ruble in all three ape groups. These res&s demonslrate that 
the funclional changes pmduccd by balloon valvuloplasty 
are equivalent in older and younger patientr. 
II 15 a&o clinically impOrtant that complications occurred 
no more frequently in the oldest patiems than in padents in 
the youngest group. and iwhospital mortality rates were also 
similar in patients ~70 years and those 280 years of age. 
This in-husoilal morlalilv rate was still substantial. however. 
ranging f&n 8.5% in Ihe youngest group to 9.4% in the 
olde%l. 
Follow~p wuu&. Al last fo!low-up. there were more 
Falicnt5 in the oldest age group m functional class 111 or IV 
as well as a signifwmtly lower mortality rate in the 70 to 79 
year old patients IIS%1 than in the other two groups 124% 
and 28%. respecrwelyl. The reasons for these differenccr 
rcmam uncertain though they cauld relate to coexislem dwasc 
procrsses. Alternatively. the lwer mortality for the middle age 
group (70 10 79 years, may just bc a statirtical abermdon. 
Univdriale and multivariate analysis Gf variable\ paslbly re- 
lated to monalitg were performed in an attempt to identify 
patient5 at increased risk of death during follow-up. Only Izft 
ventricular funclion and cardiac outpui emcrged as impananl 
faclors in all age croups. Age alone is probably not an immr- 
KmC factor in monalily al f&w-up. rmce the observed &x- 
!alilymte~ofY% lo28% atz mean of7 months inrhe ywngeesl 
I<70 years) and oldest (~80 yews\ groups is so much hi&her 
than lhdl expected by age alone. Although there was an inverse 
r&ion between events al 6 months and age, this relation mny 
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